Benefits of Decreased Mortality Risk from Reductions in Primary Mobile Source Fine Particulate Matter: A Limited Data Approach for Urban Areas Worldwide von Greco, Susan L., Belova, Anna, Huang, Jin

Volltext

A method to screen U.S. environmental biomonitoring data for race/ethnicity and income-related disparity von Belova, Anna, Greco, Susan L, Riederer, Anne M, Olsho, Lauren E W, Corrales, Mark A

Volltext

Spatial patterns of mobile source particulate matter emissions-to-exposure relationships across the United States von Greco, Susan L., Wilson, Andrew M., Spengler, John D., Levy, Jonathan I.

Volltext

An approach to estimating the environmental burden of cancer from known and probable carcinogens: application to Ontario, Canada von Greco, Susan Lavinia, MacIntyre, Elaina, Young, Stephanie, Warden, Hunter, Drudge, Christopher, Kim, JinHee, Candido, Elisa, Demers, Paul, Copes, Ray

Volltext

Evaluating Efficiency-Equality Tradeoffs for Mobile Source Control Strategies in an Urban Area von Levy, Jonathan I, Greco, Susan L, Melly, Steven J, Mukhi, Neha

Volltext

Factors Influencing Mobile Source Particulate Matter Emissions-to-Exposure Relationships in the Boston Urban Area von Greco, Susan L, Wilson, Andrew M, Hanna, Steven R, Levy, Jonathan I

Volltext

Global Climate Implications for Homelessness: A Scoping Review von Kidd, Sean A., Greco, Susan, McKenzie, Kwame

Volltext

The Importance of Population Susceptibility for Air Pollution Risk Assessment: A Case Study of Power Plants near Washington, DC von Levy, Jonathan I., Greco, Susan L., Spengler, John D.

Volltext

Estimated burden of disease from arsenic in drinking water supplied by domestic wells in the United States von Greco, Susan Lavinia, Belova, Anna, Haskell, Jacqueline, Backer, Lorraine

Volltext

Oral tablet vaccination against SARS-CoV-2 spike boosts cross-reactive serum and mucosal neutralizing antibodies following mRNA vaccination: a phase 2 clinical trial von johnson, susan, Jegede, Clara B, Gutierrez, Samanta, Greco, Susan, Cummings, James, Gottlieb, Keith A, Tucker, Sean N

Volltext

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial von le Roux, Carel W, Prof, Astrup, Arne, Prof, Fujioka, Ken, MD, Greenway, Frank, Prof, Lau, David C W, Prof, Van Gaal, Luc, Prof, Ortiz, Rafael Violante, MD, Wilding, John P H, Prof, Skjøth, Trine V, MD, Manning, Linda Shapiro, MD, Pi-Sunyer, Xavier, Prof

Volltext

Correction to: Global Climate Implications for Homelessness: A Scoping Review von Kidd, Sean A., Greco, Susan, McKenzie, Kwame

Volltext

Estimates of healthcare utilisation and deaths from waterborne pathogen exposure in Ontario, Canada von Greco, Susan Lavinia, Drudge, Christopher, Fernandes, Reisha, Kim, JinHee, Copes, Ray

Volltext

Estimated Annual Deaths, Hospitalizations, and Emergency Department and Physician Office Visits from Foodborne Illness in Ontario von Drudge, Christopher, Greco, Susan, Kim, JinHee, Copes, Ray

Volltext

Optimization of Urban Transportation Fleet PM2.5 Emission Reduction Strategies Using an Intake Fraction Framework von Greco, Susan

Volltext

Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Three Years' Experience von Higashihara, Eiji, Torres, Vicente E, Chapman, Arlene B, Grantham, Jared J, Bae, Kyongtae, Watnick, Terry J, Horie, Shigeo, Nutahara, Kikuo, Ouyang, John, Krasa, Holly B, Czerwiec, Frank S

Volltext

Ragaglitazar Improves Glycemic Control and Lipid Profile in Type 2 Diabetic Subjects von Saad, Mohammed F., Greco, Susan, Osei, Kwame, Lewin, Andrew J., Edwards, Christopher, Nunez, Margarita, Reinhardt, Rickey R.

Volltext

Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic Subjects: A 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone arm von SAAD, Mohammed F, GRECO, Susan, OSEI, Kwame, LEWIN, Andrew J, EDWARDS, Christopher, NUNEZ, Margarita, REINHARDT, Rickey R

Volltext

Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12-week, double-blind, randomized, placebo-controlled, multicentre trial von Pattzi, H. M. R., Pitale, S., Alpizar, M., Bennett, C., O'Farrell, A. M., Li, J., Cherrington, J. M., Guler, H.-P.

Volltext

Treatment of type 2 diabetes with a combination regimen of repaglinide plus pioglitazone von Jovanovic, Lois, Hassman, David R, Gooch, Brent, Jain, Rajeev, Greco, Susan, Khutoryansky, Naum, Hale, Paula M

Volltext